Shares Buck Market Downtrend on Positive Stem-Cell Therapy Data

Shares Buck Market Downtrend on Positive Stem-Cell Therapy Data

By: Dylan Sikes – News

Monday, May 10, 2021

There are many uses for stem-cell therapy. Schizophrenia is one of the top causes of suicide. Today a company is hoping it can help schizophrenia patients resistant to electroconvulsive therapy with stem-cell therapy. 

Therapeutic Solutions International, Inc., (OTCPK:TSOI), and its subsidiary Campbell Neurosciences, announced that a previously filed stem cell therapy could reduce behavioral abnormalities associated with schizophrenia. The company is working towards filing with the FDA an Investigational New Drug (IND) application to administer the stem cells in patients who are non-responsive to electroconvulsive therapy.

While markets have been trending down today, shares of TSOI were up almost 8% in early afternoon trading. 

Copyright © 2021 All rights reserved. Republication or redistribution of's content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Investing in Big Data Could Prove Lucrative For This Micro Cap
Stock Pops +284% Following Cuban Business License
Micro Cap Soars On Portable Ventilator Announcement
Most Popular
FREE Newsletter Favorites

Back to Top